Loading company…
VBI Vaccines Inc., based in Cambridge, US, develops vaccine and immunotherapy candidates for infectious diseases and cancers.
Founded in 2001 and based in Cambridge, US, VBI Vaccines Inc. develops vaccine and immunotherapeutic candidates that enhance the immune system against infectious diseases and aggressive cancers, using virus-like particle technology. The company went public in February 2012 and has completed 19 deals. Jeffrey Baxter is CEO, and Kelley Carson is also noted in leadership. It has raised a total of USD 70.00 mn, most recently through venture debt of USD 100.00 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in